This inventor holds 4 USPTO granted patents. Top assignee: Smithkline Beecham Corporation. Active years: 2001-2003.
Location History:
- Chester Springs, PA (US) (2001)
- Alamo, CA (US) (2002 - 2003)
Company Filing History:
Years Active: 2001-2003
Title: Susan B Dillon: Innovator in Anti-Cancer and Infection Treatment
Introduction
Susan B Dillon is a prominent inventor based in Alamo, CA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for cancer and bacterial infections. With a total of 4 patents to her name, Dillon's work has the potential to impact many lives.
Latest Patents
Dillon's latest patents include innovative compounds and methods aimed at addressing critical health issues. One of her notable inventions is related to substituted imidazoles that exhibit anti-cancer and cytokine inhibitory activity. This invention focuses on novel 2-alkyl substituted imidazoles of formula (I), which are useful for treating CSBP kinase mediated diseases. Another significant patent involves the use of PDE 4-specific inhibitors to reduce the severity of bacterial infections following respiratory viral infections. This method provides a proactive approach to managing post-viral bacterial infections by administering a PDE 4-specific inhibitor during or after a viral infection.
Career Highlights
Dillon is currently associated with SmithKline Beecham Corporation, where she continues to advance her research and development efforts. Her work has garnered attention in the pharmaceutical industry, showcasing her dedication to improving health outcomes through innovative solutions.
Collaborations
Throughout her career, Dillon has collaborated with esteemed colleagues, including Kenneth A Lord and Sandra D Griego. These partnerships have contributed to the success of her projects and the advancement of her inventions.
Conclusion
Susan B Dillon stands out as a key figure in the realm of pharmaceutical innovation. Her contributions to anti-cancer and infection treatment reflect her commitment to enhancing healthcare through scientific advancements.